Downmodulation of CCR7 by HIV-1 Vpu Results in Impaired Migration and Chemotactic Signaling within CD4+ T Cells

Cell Reports

Volumn 7, Issue 6, 2014, Pages 2019-2030

  Ramirez, Peter W ^a   Famiglietti, Marylinda ^a,c,d   Sowrirajan, Bharatwaj ^b   DePaula Silva, AnaBeatriz ^a   Rodesch, Christopher ^a   Barker, Edward ^b   Bosque, Alberto ^a   Planelles, Vicente ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CELL ANTIGEN; CHEMOKINE RECEPTOR CCR7; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TETHERIN ANTIGEN; UNCLASSIFIED DRUG; VPU PROTEIN; CCL19 PROTEIN, HUMAN; CCR7 PROTEIN, HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LIGAND; VIRUS PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; INTRACELLULAR TRANSPORT; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TRANS GOLGI NETWORK; VIRUS REPLICATION; CELL MOTION; DOWN REGULATION; HEK293 CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; NEUTROPHIL CHEMOTAXIS; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CCL19; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LIGANDS; RECEPTORS, CCR7; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84903382162     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.015     Document Type: Article

References (65)

1. Barlow A.L., Macleod A., Noppen S., Sanderson J., Guerin C.J. Colocalization analysis in fluorescence micrographs: verification of a more accurate calculation of pearson's correlation coefficient. Microsc. Microanal. 2010, 16:710-724.
2. Binette J., Dubé M., Mercier J., Halawani D., Latterich M., Cohen E.A. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 2007, 4:75.
3. Bosque A., Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ Tcells. Blood 2009, 113:58-65.
4. Butticaz C., Michielin O., Wyniger J., Telenti A., Rothenberger S. Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J.Virol. 2007, 81:1502-1505.
5. Cirone M., Conte V., Farina A., Valia S., Trivedi P., Granato M., Santarelli R., Frati L., Faggioni A. HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization. Virol. J. 2012, 9:92.
6. Debes G.F., Arnold C.N., Young A.J., Krautwald S., Lipp M., Hay J.B., Butcher E.C. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 2005, 6:889-894.
7. Douglas J.L., Viswanathan K., McCarroll M.N., Gustin J.K., Früh K., Moses A.V. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a betaTrCP-dependent mechanism. J.Virol. 2009, 83:7931-7947.
8. Dubé M., Roy B.B., Guiot-Guillain P., Mercier J., Binette J., Leung G., Cohen E.A. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J.Virol. 2009, 83:4574-4590.
9. Dubé M., Roy B.B., Guiot-Guillain P., Binette J., Mercier J., Chiasson A., Cohen E.A. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 2010, 6:e1000856.
10. Evrard-Todeschi N., Gharbi-Benarous J., Bertho G., Coadou G., Megy S., Benarous R., Girault J.P. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP. Peptides 2006, 27:194-210.
11. Förster R., Schubel A., Breitfeld D., Kremmer E., Renner-Müller I., Wolf E., Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
12. Hauser H., Lopez L.A., Yang S.J., Oldenburg J.E., Exline C.M., Guatelli J.C., Cannon P.M. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 2010, 7:51.
13. Herbein G., Khan K.A. Is HIV infection a TNF receptor signalling-driven disease?. Trends Immunol. 2008, 29:61-67.
14. Höpken U.E., Winter S., Achtman A.H., Krüger K., Lipp M. CCR7 regulates lymphocyte egress and recirculation through body cavities. J.Leukoc. Biol. 2010, 87:671-682.
15. Hrecka K., Swigut T., Schindler M., Kirchhoff F., Skowronski J. Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1. J.Virol. 2005, 79:10650-10659.
16. Iwabu Y., Fujita H., Kinomoto M., Kaneko K., Ishizaka Y., Tanaka Y., Sata T., Tokunaga K. HIV-1 accessory protein Vpu internalizes cell-surfaceBST-2/tetherin through transmembrane interactions leading to lysosomes. J.Biol. Chem. 2009, 284:35060-35072.
17. Jamieson B.D., Zack J.A. Invivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J.Virol. 1998, 72:6520-6526.
18. Kerkau T., Bacik I., Bennink J.R., Yewdell J.W., Húnig T., Schimpl A., Schubert U. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J.Exp. Med. 1997, 185:1295-1305.
19. Kirchhoff F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 2010, 8:55-67.
20. Kobayashi T., Ode H., Yoshida T., Sato K., Gee P., Yamamoto S.P., Ebina H., Strebel K., Sato H., Koyanagi Y. Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J.Virol. 2011, 85:932-945.
21. Luther S.A., Tang H.L., Hyman P.L., Farr A.G., Cyster J.G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA 2000, 97:12694-12699.
22. Magadán J.G., Bonifacino J.S. Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu. J.Virol. 2012, 86:757-772.
23. Magadán J.G., Pérez-Victoria F.J., Sougrat R., Ye Y., Strebel K., Bonifacino J.S. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 2010, 6:e1000869.
24. Maldarelli F., Chen M.Y., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J.Virol. 1993, 67:5056-5061.
25. Malim M.H., Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 2008, 3:388-398.
26. Mangeat B., Gers-Huber G., Lehmann M., Zufferey M., Luban J., Piguet V. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 2009, 5:e1000574.
27. Marassi F.M., Ma C., Gratkowski H., Straus S.K., Strebel K., Oblatt-Montal M., Montal M., Opella S.J. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc. Natl. Acad. Sci. USA 1999, 96:14336-14341.
28. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., Benarous R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1998, 1:565-574.
29. McNatt M.W., Zang T., Bieniasz P.D. Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog. 2013, 9:e1003299.
30. Mitchell R.S., Katsura C., Skasko M.A., Fitzpatrick K., Lau D., Ruiz A., Stephens E.B., Margottin-Goguet F., Benarous R., Guatelli J.C. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 2009, 5:e1000450.
31. Moll M., Andersson S.K., Smed-Sörensen A., Sandberg J.K. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 2010, 116:1876-1884.
32. Moutaftsi M., Brennan P., Spector S.A., Tabi Z. Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J.Virol. 2004, 78:3046-3054.
33. Nomaguchi M., Fujita M., Adachi A. Role of HIV-1 Vpu protein for virus spread and pathogenesis. Microbes Infect. 2008, 10:960-967.
34. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., Förster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004, 21:279-288.
35. Otero C., Groettrup M., Legler D.F. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J.Immunol. 2006, 177:2314-2323.
36. Pantaleo G., Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 2006, 6:417-423.
37. Park S.H., Mrse A.A., Nevzorov A.A., Mesleh M.F., Oblatt-Montal M., Montal M., Opella S.J. Three-dimensional structure of the channel-forming trans-membrane domain of virus protein "u" (Vpu) from HIV-1. J.Mol. Biol. 2003, 333:409-424.
38. Perez-Patrigeon S., Vingert B., Lambotte O., Viard J.P., Delfraissy J.F., Thèze J., Chakrabarti L.A. HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression. AIDS 2009, 23:1197-1207.
39. Reif K., Ekland E.H., Ohl L., Nakano H., Lipp M., Förster R., Cyster J.G. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002, 416:94-99.
40. Rong L., Zhang J., Lu J., Pan Q., Lorgeoux R.P., Aloysius C., Guo F., Liu S.L., Wainberg M.A., Liang C. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J.Virol. 2009, 83:7536-7546.
41. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004, 22:891-928.
42. Sallusto F., Lenig D., Förster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
43. Sandberg J.K., Andersson S.K., Bächle S.M., Nixon D.F., Moll M. HIV-1 Vpu interference with innate cell-mediated immune mechanisms. Curr. HIV Res. 2012, 10:327-333.
44. Schubert U., Ferrer-Montiel A.V., Oblatt-Montal M., Henklein P., Strebel K., Montal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 1996, 398:12-18.
45. Schubert U., Antón L.C., Bacík I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K., Yewdell J.W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J.Virol. 1998, 72:2280-2288.
46. Schwartz S., Felber B.K., Benko D.M., Fenyö E.M., Pavlakis G.N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J.Virol. 1990, 64:2519-2529.
47. Shah A.H., Sowrirajan B., Davis Z.B., Ward J.P., Campbell E.M., Planelles V., Barker E. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 2010, 8:397-409.
48. Skasko M., Wang Y., Tian Y., Tokarev A., Munguia J., Ruiz A., Stephens E.B., Opella S.J., Guatelli J. HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J.Biol. Chem. 2012, 287:58-67.
49. Strebel K. HIV accessory genes Vif and Vpu. Adv. Pharmacol. 2007, 55:199-232.
50. Strebel K., Klimkait T., Martin M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 1988, 241:1221-1223.
51. Tiganos E., Friborg J., Allain B., Daniel N.G., Yao X.J., Cohen E.A. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein. Virology 1998, 251:96-107.
52. Tilton B., Ho L., Oberlin E., Loetscher P., Baleux F., Clark-Lewis I., Thelen M. Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J.Exp. Med. 2000, 192:313-324.
53. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
54. Vander Lugt B., Tubo N.J., Nizza S.T., Boes M., Malissen B., Fuhlbrigge R.C., Kupper T.S., Campbell J.J. CCR7 plays no appreciable role in trafficking of central memory CD4 Tcells to lymph nodes. J.Immunol. 2013, 191:3119-3127.
55. Venzke S., Michel N., Allespach I., Fackler O.T., Keppler O.T. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J.Virol. 2006, 80:11141-11152.
56. Vigan R., Neil S.J. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J.Virol. 2010, 84:12958-12970.
57. Vigan R., Neil S.J. Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin. J.Virol. 2011, 85:9737-9748.
58. Ward J., Davis Z., DeHart J., Zimmerman E., Bosque A., Brunetta E., Mavilio D., Planelles V., Barker E. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 2009, 5:e1000613.
59. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J.Virol. 1992, 66:7193-7200.
60. Willimann K., Legler D.F., Loetscher M., Roos R.S., Delgado M.B., Clark-Lewis I., Baggiolini M., Moser B. The chemokine SLC is expressed in Tcell areas of lymph nodes and mucosal lymphoid tissues and attracts activated Tcells via CCR7. Eur. J. Immunol. 1998, 28:2025-2034.
61. Wray V., Federau T., Henklein P., Klabunde S., Kunert O., Schomburg D., Schubert U. Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. Int. J. Pept. Protein Res. 1995, 45:35-43.
62. Wu D., Huang C.K., Jiang H. Roles of phospholipid signaling in chemoattractant-induced responses. J.Cell Sci. 2000, 113:2935-2940.
63. Wu G., Xu G., Schulman B.A., Jeffrey P.D., Harper J.W., Pavletich N.P. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol. Cell 2003, 11:1445-1456.
64. Yoshida R., Nagira M., Kitaura M., Imagawa N., Imai T., Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J.Biol. Chem. 1998, 273:7118-7122.
65. Younes S.A., Yassine-Diab B., Dumont A.R., Boulassel M.R., Grossman Z., Routy J.P., Sekaly R.P. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ Tcells endowed with proliferative capacity. J.Exp. Med. 2003, 198:1909-1922.